Eli Lilly and Co.’s loss in May of a patent-infringement lawsuit brought by Ariad Pharmaceuticals
Inc. went down as the 6th-largest such jury award last year, a Bloomberg analysis shows.
A Massachusetts jury awarded Ariad $65.2 million after unanimously agreeing that Lilly’s Evista and Xigris drugs infringed
on a patent held by the Cambridge, Mass., drug developer.
Jury awards for patent verdicts nearly tripled last year from 2005—to $1 billion—as
companies took to the courts to protect valuable technology, and increasingly trusted juries to sort through complex disagreements.
The largest jury award last year for infringing a patent, $307 million, went to Los Altos,
Calif.-based Rambus Inc. after it sued Hynix Semiconductor Inc. of Inchon, South Korea, over use of random access memory.
A judge cut the figure to $133.4 million.